APA (7th ed.) Citation

YL, N., Y, Y., XB, T., MF, H., & DM, W. (2026). Sequential targeted therapy in synchronous dual-primary lung adenocarcinomas with EGFR and RET alterations: A 5-year follow-up case report. Frontiers in oncology, 16, 1769932. https://doi.org/10.3389/fonc.2026.1769932

Chicago Style (17th ed.) Citation

YL, Niu, Yang Y, Teng XB, Han MF, and Wang DM. "Sequential Targeted Therapy in Synchronous Dual-primary Lung Adenocarcinomas with EGFR and RET Alterations: A 5-year Follow-up Case Report." Frontiers in Oncology 16 (2026): 1769932. https://doi.org/10.3389/fonc.2026.1769932.

MLA (9th ed.) Citation

YL, Niu, et al. "Sequential Targeted Therapy in Synchronous Dual-primary Lung Adenocarcinomas with EGFR and RET Alterations: A 5-year Follow-up Case Report." Frontiers in Oncology, vol. 16, 2026, p. 1769932, https://doi.org/10.3389/fonc.2026.1769932.